Skip to content

Restoring Non-Emergent Cardiovascular Care in the Peri- COVID-19 Era

Restoring Non-Emergent Cardiovascular Care in the Peri-COVID 19 Era

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04636021
Acronym
RECIPE
Enrollment
1000
Registered
2020-11-19
Start date
2020-08-01
Completion date
2022-06-30
Last updated
2020-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Corona Virus Infection

Keywords

COVID-19 testing, outpatient procedures

Brief summary

Pre-procedure and Short-Term COVID-19 Testing of Outpatients Undergoing Non-emergent Invasive Cardiovascular Procedures

Interventions

DIAGNOSTIC_TESTCOVID-19 testing

Pre and post procedure COVID-19 testing for patients undergoing outpatient cardiac procedures.

Sponsors

Pinnacle Health Cardiovascular Institute
Lead SponsorNETWORK

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

• Outpatients undergoing non-emergent invasive cardiac diagnostic, cardiac interventional, peripheral diagnostic, peripheral interventional, structural heart interventional, electrophysiology diagnostic, ablation, or device implantation procedures

Exclusion criteria

* Previous positive COVID-19 test result * Patients with symptoms concerning for COVID-19, including (but not limited to): Fever \> 38˚C, shortness of breath and/or cough in greater severity from baseline, sore throat, anosmia / dysgeusia, vomiting/diarrhea within 24 hours prior to procedure * Emergent status including (but not limited to) acute coronary syndromes, acute limb ischemia, stroke, need of temporary pacemaker * Non-outpatient status including (but not limited to) patients evaluated in the hospital, observational unit, or emergency department

Design outcomes

Primary

MeasureTime frame
Number of subjects who contract COVID-19 while hospitalized for elective outpatient proceduresThrough 30 day follow up period

Secondary

MeasureTime frame
Patient perception of the effect of pre and post procedure COVID-19 testing on risk of contracting COVID-19 while hospitalized for an elective outpatient procedure.Through 30 day follow up period

Countries

United States

Contacts

Primary ContactWilliam Bachinsky, MD
bachinskywb@upmc.edu(717) 731-0101

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026